Stay updated on ADI-PEG 20 with Gemcitabine/Docetaxel in Sarcomas/Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the ADI-PEG 20 with Gemcitabine/Docetaxel in Sarcomas/Lung Cancer Clinical Trial page.

Latest updates to the ADI-PEG 20 with Gemcitabine/Docetaxel in Sarcomas/Lung Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision: v3.4.2 was added. The previous government funding-status notice and Revision: v3.4.1 were removed.SummaryDifference0.4%

- Check31 days agoChange DetectedAdded a system-wide notice about a lapse in government funding affecting site updates and directing users to cc.nih.gov and opm.gov for status. Updated the site to version v3.4.1 (from v3.4.0).SummaryDifference0.4%

- Check38 days agoChange DetectedThe changes are limited to UI and metadata updates (glossary display, new labels such as 'Last Update Submitted that Met QC Criteria', 'Last Update Posted', 'No FEAR Act Data', and revision 'v3.4.0'), with no changes to core study content, eligibility criteria, outcomes, or contacts. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check52 days agoChange DetectedSite revision tag updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check73 days agoChange DetectedIntroduced a dedicated Locations section listing California, Missouri, and New York, replacing the previous per-state location entries; the page version updated to v3.3.3.SummaryDifference0.4%

- Check81 days agoChange DetectedMia Weiss, M.D. was added as an investigator and Brian A. Van Tine, M.D., Ph.D. was removed from the study record.SummaryDifference0.4%

Stay in the know with updates to ADI-PEG 20 with Gemcitabine/Docetaxel in Sarcomas/Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADI-PEG 20 with Gemcitabine/Docetaxel in Sarcomas/Lung Cancer Clinical Trial page.